What FCH Group does

FCH Group Ltd. is a privately held specialty chemical company founded in 2008 and headquartered in Chernihiv, Ukraine, providing custom synthesis services in medicinal chemistry to pharmaceutical companies worldwide. Its core technology base is a 2,000 sq.ft research facility equipped with 29 fume hoods, staffed by more than 20 PhD scientists with expertise in catalysis, heterocycle synthesis, amino acid chemistry, and the handling of water- and air-reactive compounds. The firm operates a sales-led model with three revenue streams: (i) Custom Synthesis Services — bespoke compound design and re-synthesis executed by its chemists with progress reporting and estimated delivery dates; (ii) Compound Library Sales — catalog licenses spanning a 5,219,956-compound Building Blocks Collection, a 1.8M+ lead-like Screening Library, Targeted Libraries (40+ named protein targets with pSEA >50), seven specialized Fragment Libraries, and Focused Libraries; and (iii) Reagent Sales of over 5,213,995 advanced reagents, with the majority of reactive intermediates available in 20+ gram quantities. Quality verification is documented via NMR (300–500 MHz), GC-MS, HPLC-MS, FT-IR, and elemental analysis, backed by 95%/90% purity warranties.

Distribution and customer reach are achieved through self-service procurement channels — the company's own website with downloadable SDF files and the ChemSpace marketplace (a 2016 co-founded platform with Enamine, ChemBridge, and UORSY covering 15M+ unique molecular building blocks with EU/US offices). Products are sold as dry powders, DMSO solutions, dry films, in vials/microtubes, or in 96/384 well plates, shipped globally via DHL and FedEx. The customer base is horizontally segmented toward pharmaceutical discovery programs (drug discovery, lead identification, fragment-based drug discovery, virtual screening, SAR studies) with no named end-customer logos disclosed. FCH Group operates as a portfolio company of Audax Private Equity ($19.5B AUM), which has used it as a Buy & Build platform — most recently executing the April 2025 acquisition of Sanitary Solutions Group (Audax's 1,500th add-on). Pricing is not publicly disclosed; the firm offers free project feedback and NDA availability prior to discussion as part of its sales motion.

Name

FCH Group

Legal name

FCH Group Ltd.

Website

https://fchgroup.net

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

11–50 employees

Short description

FCH Group Ltd. is a Ukrainian-based medicinal chemistry company providing custom synthesis services and licensed compound libraries (5M+ building blocks, 1.8M+ screening compounds, targeted and fragment libraries) to pharmaceutical companies worldwide, distributed via the ChemSpace marketplace.

Ownership category

akta.pro rank

Product category

Medicinal Chemistry Services & Compound Libraries

NAICS

Scientific Research and Development Services (5417), Medicinal and Botanical Manufacturing (325411)

SIC

Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM)

Keywords

• Custom synthesis services
• Medicinal chemistry
• Compound libraries
• Building blocks reagents
• Drug discovery chemicals

Headquarters

HQ city

Chernihiv

HQ country

Ukraine

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Infrastructure

Revenue model

1. Custom Synthesis Services: Custom synthesis of compounds not available in the existing database, designed and obtained by FCH chemists. Customers receive progress updates and estimated delivery dates.
2. Compound Library Sales: Sale of building blocks, screening compounds, fragment libraries, focused libraries, and targeted libraries. Compounds available in various formats including dry powders, DMSO solutions, or dry films in vials or 96/384 well plates.
3. Reagent Sales: Sale of advanced reagents for synthesis, with majority of reactive intermediates available in quantities of over 20 grams from the database of 5,213,995 reagents

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

FCH Group provides custom synthesis in medicinal chemistry and sells large curated compound libraries (building blocks, screening libraries, targeted libraries, fragment libraries, and focused libraries) to pharmaceutical companies worldwide. Offerings are backed by a database of more than 5.2 million reagents and approximately 1.85 million drug-like screening compounds, with the capability to resynthesize compounds not present in the existing catalog on request.

Product overview

FCH Group is a chemical company providing custom synthesis services and compound libraries to pharmaceutical companies worldwide. The core offering consists of Building Blocks (5.2M+ medicinal chemistry building blocks), Screening Libraries (1.8M+ lead-like compounds for biological screening), Targeted Libraries (protein-specific compound sets), Fragment Libraries (8 fragment collections for FBDD), and Focused Libraries (lead-optimized collections). Products are distributed through the company's own database and the ChemSpace online platform. The company operates research facilities in Chernigov, Ukraine with 2,000 sq.ft of laboratory space.

Differentiator

Problem solved

Functional benefit

Products and services

• Building Blocks Collection

Quantifiable outcome

• 95% purity standard for reagents, 90% purity for screening compounds
• +3 more outcomes

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Four partnerships are on record, tiered core.

• Enamine Ltd.coreStrategic or Co-development Partner · 24 October 2016Collaboration to extend compound library synthesis program. Enamine, a chemical company and producer of building blocks and screening libraries, signed a collaboration agreement with FCH Group to expand synthesis capabilities and compound offerings.
• ChemBridge CorporationcoreStrategic or Co-development Partner · 1 March 2016Partnership to launch ChemSpace, a global e-procurement marketplace. Together with Enamine, UORSY, and FCH Group, created the world's largest chemicals library database encompassing over 15 million unique molecular building blocks.
• UORSYcoreStrategic or Co-development Partner · 1 March 2016Partnership to launch ChemSpace, a global e-procurement marketplace combining expertise of multiple chemical companies to create the world's largest chemicals library with over 15 million unique molecular building blocks.
• Chem-SpacecoreChannel Partner/ Reseller/ DistributorOfficial distributor with offices in EU and US. Chem-Space operates the chem-space.com marketplace for searching, purchasing and selling chemical building blocks from FCH Group and partner companies.

Scale indicators7 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Sigma-Aldrich (Merck KGaA): Broad incumbent in research chemicals and life science supplies. While far larger and broader in scope, it overlaps with FCH in building blocks, screening compounds, and reagents sold to pharmaceutical researchers.

Direct peers

• ChemBridge Corporation: Direct peer and ChemSpace co-founding partner. ChemBridge sells screening libraries, building blocks, and targeted compounds to the same pharmaceutical drug discovery customer base served by FCH.
• Combi-Blocks: Direct peer supplying screening compounds and building blocks for medicinal chemistry and drug discovery. The catalog and pricing model closely mirror FCH's building blocks and screening library products.
• Life Chemicals: Direct peer producing screening libraries, focused libraries, and building blocks for pharmaceutical drug discovery programs. Product taxonomy (screening, focused, fragment) closely mirrors FCH's library portfolio.
• Enamine Ltd. Direct peer and explicit FCH partner in compound library synthesis and the ChemSpace marketplace. Enamine produces building blocks, screening libraries, and custom synthesis services for pharma drug discovery - the same product categories and buyer base as FCH.
• Asinex: Direct peer offering building blocks, screening libraries, and focused libraries (including target-specific and FBDD-oriented sets) for pharma drug discovery - direct overlap with FCH's library portfolio categories.
• Princeton BioMolecular Research: Direct peer offering custom synthesis and screening libraries for pharma and biotech drug discovery, with comparable small-molecule medicinal chemistry capabilities as FCH.
• UORSY: Direct peer and ChemSpace co-founding partner providing compound libraries and custom synthesis for early-stage drug discovery, with overlapping product formats (SDF, building blocks, screening collections).
• ChemDiv: Direct peer offering screening libraries, building blocks, and custom synthesis to pharmaceutical and biotech customers. Overlapping lead-like and targeted library offerings position ChemDiv as a closely comparable competitor to FCH.

Others

• MolPort: Chemicals marketplace aggregating catalogs from multiple suppliers (similar role to Chem-Space). Comparable as a discovery-to-procurement platform that competes with the channel through which FCH distributes its compounds.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/fch-group-llp

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about FCH Group